Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 87–87 | Cite as

Dolutegravir

Hepatic and renal toxicity: 3 case reports
Case report
  • 12 Downloads

Reference

  1. Mondi A, et al. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. Journal of the International AIDS Society 22: No. 1, Jan 2019. Available from: URL: http://doi.org/10.1002/jia2.25227 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations